Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 51751-51800 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05182944
A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCC
PHASE2Recruiting
130 participants
Started: Jan 15, 2022 · Completed: Jan 15, 2027
1 condition1 sponsor1 location
NCT05205603
Efficacy of Mesalazine Combined With Biologics in the Treatment of Moderate to Severe Ulcerative Colitis
PHASE4Recruiting
438 participants
Started: Jan 15, 2022 · Completed: Jan 15, 2025
4 conditions1 sponsor11 locations
NCT05215665
GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma
NARecruiting
146 participants
Started: Jan 15, 2022 · Completed: Jan 15, 2026
1 condition1 sponsor1 location
NCT06727981
First-Line and Neoadjuvant Immunotherapy for Gastric Cancer
N/ARecruiting
500 participants
Started: Jan 15, 2022 · Completed: Jan 15, 2028
2 conditions1 sponsor1 location
NCT05257785
Lymfit to Improve the Fitness and Quality of Life in Lymphoma Survivors
NARecruiting
50 participants
Started: Jan 15, 2022 · Completed: Dec 1, 2024
2 conditions3 sponsors1 location
NCT05554003
Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study
PHASE2Recruiting
46 participants
Started: Jan 14, 2022 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT04981145
The Efficacy and Safety of Iguratimod (IGU) in the Treatment of Primary Sjögren's Syndrome
PHASE4Recruiting
78 participants
Started: Jan 14, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05192798
Albumin-Bound Paclitaxel Combined With Antiangiogenic Agents in First-line Treatment of Relapsed or Metastatic TNBC
PHASE2Recruiting
128 participants
Started: Jan 14, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor1 location
NCT05061030
Mesenchymal Stromal Cells to Treat Type 1 Diabetes in Children and Adolescents
PHASE1/PHASE2Recruiting
66 participants
Started: Jan 14, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05176769
Artificial Intelligence for Automated Clinical Data Exploration From Electronic Medical Records (CardioMining-AI)
N/ARecruiting
60,000 participants
Started: Jan 14, 2022 · Completed: Mar 1, 2026
3 conditions8 sponsors9 locations
NCT05215353
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
PHASE4Recruiting
350 participants
Started: Jan 14, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors3 locations
NCT05043051
Autoimmune Basis for Postural Tachycardia Syndrome
NARecruiting
80 participants
Started: Jan 14, 2022 · Completed: Jul 31, 2026
1 condition2 sponsors1 location
NCT05152472
A Prospective, Randomized, Multicenter, Comparative Study of the Efficacy of Imatinib Resumption Combined with Atezolizumab Versus Imatinib Resumption Alone in Patients with Unresectable Advanced Gastrointestinal Stromal Tumors (GIST) After Failure of Standard Treatments
PHASE2Recruiting
110 participants
Started: Jan 14, 2022 · Completed: Oct 31, 2027
3 conditions1 sponsor12 locations
NCT05188508
Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
PHASE2Recruiting
57 participants
Started: Jan 14, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors10 locations
NCT06773065
Central Awareness in Women With Endometriosis
N/ARecruiting
310 participants
Started: Jan 14, 2022 · Completed: Jan 31, 2025
1 condition1 sponsor1 location
NCT05067634
Safety and Efficacy Study of Cenobamate in Pediatric Subjects 2-17 Years of Age With Partial-onset (Focal) Seizures
PHASE3Recruiting
140 participants
Started: Jan 14, 2022 · Completed: Jul 31, 2026
1 condition1 sponsor55 locations
NCT05190172
PRO-GLIO: PROton Versus Photon Therapy in IDH-mutated Diffuse Grade II and III GLIOmas
NARecruiting
225 participants
Started: Jan 14, 2022 · Completed: Dec 31, 2043
3 conditions13 sponsors1 location
NCT05851014
A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
PHASE3Recruiting
350 participants
Started: Jan 14, 2022 · Completed: Jan 30, 2027
1 condition1 sponsor52 locations
NCT05243082
Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms
NARecruiting
20 participants
Started: Jan 14, 2022 · Completed: Nov 11, 2029
1 condition4 sponsors1 location
NCT05154994
Tremelimumab + Durvalumab(MEDI4736)+ Belinostat in Urothelial Carcinoma
PHASE1Recruiting
9 participants
Started: Jan 14, 2022 · Completed: Nov 30, 2027
4 conditions2 sponsors1 location
NCT05139017
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
PHASE2/PHASE3Recruiting
290 participants
Started: Jan 14, 2022 · Completed: Sep 24, 2027
2 conditions1 sponsor113 locations
NCT05197920
Diabetes RElated to Acute Pancreatitis and Its Mechanisms
N/ARecruiting
800 participants
Started: Jan 14, 2022 · Completed: Jun 30, 2030
1 condition15 sponsors13 locations
NCT05187312
Registry for Advanced Endoscopy
N/ARecruiting
1,000 participants
Started: Jan 14, 2022 · Completed: Jan 14, 2032
3 conditions2 sponsors1 location
NCT05206890
A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer
N/ARecruiting
490 participants
Started: Jan 14, 2022 · Completed: Dec 31, 2032
1 condition15 sponsors1 location
NCT05106322
Estimation of Steatosis on Liver Transplants by Intraoperative Spectrometry
N/ARecruiting
240 participants
Started: Jan 14, 2022 · Completed: Nov 14, 2024
1 condition1 sponsor3 locations
NCT04521699
Examination of the Impact of CalmiGo's Stress Management Device on Vascular Heath and Cardiovascular Disease Risk.
NARecruiting
100 participants
Started: Jan 13, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05407636
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
PHASE3Recruiting
660 participants
Started: Jan 13, 2022 · Completed: Nov 30, 2027
6 conditions2 sponsors181 locations
NCT04873050
Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
PHASE4Recruiting
102 participants
Started: Jan 13, 2022 · Completed: Mar 1, 2026
2 conditions2 sponsors1 location
NCT05157698
Pharmacological and Behavioral Treatment After Bariatric Surgery
PHASE2/PHASE3Recruiting
160 participants
Started: Jan 13, 2022 · Completed: Jan 12, 2028
1 condition2 sponsors1 location
NCT05027685
"The Global Paradise System Registry"
N/ARecruiting
3,000 participants
Started: Jan 13, 2022 · Completed: Dec 31, 2031
1 condition1 sponsor35 locations
NCT05045612
Antibiotic Therapy in Viral Airway Infections
PHASE4Recruiting
380 participants
Started: Jan 13, 2022 · Completed: Nov 30, 2029
4 conditions2 sponsors12 locations
NCT05020080
Operant Conditioning for Rehabilitation After Stroke
NARecruiting
20 participants
Started: Jan 13, 2022 · Completed: Jul 12, 2024
1 condition2 sponsors1 location
NCT05307120
Lifestyle Monitoring and Coaching Using the Mobile DIAMETER Application in Secondary Care
NARecruiting
80 participants
Started: Jan 13, 2022 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT06324565
Role of Preoperative D-dimer Levels in the Diagnosis of Adnexal Torsion
N/ARecruiting
130 participants
Started: Jan 13, 2022 · Completed: Dec 13, 2024
1 condition1 sponsor9 locations
NCT05218785
Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a
N/ARecruiting
40 participants
Started: Jan 13, 2022 · Completed: Jan 31, 2026
2 conditions1 sponsor1 location
NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
PHASE3Recruiting
1,059 participants
Started: Jan 13, 2022 · Completed: May 31, 2026
1 condition1 sponsor118 locations
NCT05134779
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
N/ARecruiting
400 participants
Started: Jan 12, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor2 locations
NCT05294276
Prospective Registration of Taiwan Neonatal Network (TNN)
N/ARecruiting
26,500 participants
Started: Jan 12, 2022 · Completed: Dec 31, 2050
1 condition2 sponsors1 location
NCT05201638
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
PHASE3Recruiting
1,050 participants
Started: Jan 12, 2022 · Completed: Oct 31, 2032
1 condition1 sponsor91 locations
NCT05069363
Whole-Body Photobiomodulation and Chronic Pain Trial
NARecruiting
20 participants
Started: Jan 12, 2022 · Completed: Sep 30, 2023
1 condition1 sponsor1 location
NCT04848870
Dental and Periodontal Status of Patients With Sjögren's Syndrome.
N/ARecruiting
100 participants
Started: Jan 12, 2022 · Completed: Jan 12, 2032
1 condition1 sponsor1 location
NCT04876781
Korean Post-marketing Surveillance for Xeljanz XR
N/ARecruiting
200 participants
Started: Jan 12, 2022 · Completed: Dec 6, 2026
3 conditions1 sponsor1 location
NCT05752656
Short- and Long-term Behavioral, Cognitive and Motor Outcomes of Frameless Deep Brain Stimulation in Patients With Parkinson's Disease: a Prospective Observational Study
N/ARecruiting
100 participants
Started: Jan 12, 2022 · Completed: Jan 1, 2034
1 condition1 sponsor1 location
NCT05389878
Implementation of a Registry for Patients with Stroke
N/ARecruiting
600 participants
Started: Jan 12, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor4 locations
NCT05141253
Safety and Efficacy of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
EARLY_PHASE1Recruiting
24 participants
Started: Jan 12, 2022 · Completed: Nov 1, 2036
1 condition2 sponsors1 location
NCT05305859
Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML
PHASE2Recruiting
30 participants
Started: Jan 12, 2022 · Completed: Jun 30, 2027
3 conditions7 sponsors1 location
NCT04813159
Remote Ischaemic Conditioning in STEMI Patients in AFRICA
NARecruiting
1,400 participants
Started: Jan 12, 2022 · Completed: Dec 31, 2027
3 conditions22 sponsors20 locations
NCT04979078
Photobiomodulation Therapy in the Management of Hand-foot Syndrome and Hand-foot Skin Reaction
NARecruiting
40 participants
Started: Jan 12, 2022 · Completed: Aug 31, 2029
2 conditions2 sponsors2 locations
NCT05504213
A Phase Ib Study of HS-10352 Plus Fulvestrant in Patients With Advanced Breast Cancer
PHASE1Recruiting
224 participants
Started: Jan 12, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04615819
Access to Kidney Transplantation in Minority Populations
NARecruiting
398 participants
Started: Jan 11, 2022 · Completed: Dec 31, 2026
1 condition4 sponsors1 location